Helen Sabzevari - Jun 26, 2025 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Jun 26, 2025
Transactions value $
$0
Form type
4
Date filed
6/27/2025, 04:08 PM
Previous filing
May 27, 2025
Next filing
Sep 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sabzevari Helen President and CEO, Director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact 2025-06-27 0001724195

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +500K $0.00 500K Jun 26, 2025 Common Stock 500K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2 The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter.